See the DrugPatentWatch profile for valsartan
The active ingredient in valsartan is valsartan. It is a medication prescribed to treat high blood pressure and heart failure. [1]
What else is in valsartan tablets?
Beyond the active pharmaceutical ingredient, valsartan tablets contain inactive ingredients that help form the tablet and ensure its stability and effectiveness. These can include microcrystalline cellulose, povidone, crospovidone, colloidal anhydrous silica, and magnesium stearate. [1]
How does valsartan work?
Valsartan is an angiotensin II receptor blocker (ARB). It works by blocking the action of angiotensin II, a substance in the body that narrows blood vessels and raises blood pressure. By blocking this substance, valsartan helps blood vessels relax and widen, which lowers blood pressure and reduces the workload on the heart. [2]
When might valsartan lose patent protection?
The patent expiry timeline for medications like valsartan can be complex and influenced by various factors, including different patents covering different aspects of the drug. Information on specific patent expiries can be tracked through resources that monitor drug patents. [3]
Are there other medications like valsartan?
Yes, there are other ARBs available that work similarly to valsartan. Examples include losartan, olmesartan, and candesartan. These drugs are often prescribed for the same conditions. [4]
What is the difference between valsartan and other blood pressure medications?
Valsartan belongs to the ARB class of drugs. Other classes of blood pressure medications include ACE inhibitors (e.g., lisinopril), calcium channel blockers (e.g., amlodipine), and diuretics (e.g., hydrochlorothiazide). Each class works through different mechanisms to lower blood pressure. [4]
Where can I find detailed information on valsartan's formulation?
Detailed information about the specific inactive ingredients in a particular valsartan product can be found in its official prescribing information or patient information leaflet. Pharmaceutical companies provide these documents to healthcare professionals and patients. [1]
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/
4. https://www.drugpatentwatch.com/